How to navigate the production and reimbursement intricacies of bringing regenerative medicines from bench to bedside.
Mo Heidaran
Advertisement
Articles by Mo Heidaran
Advertisement
Latest Updated Articles
High-Stakes Manufacturing: Mitigating the RisksPublished: August 8th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
mRNA Covid Vaccines Display Potential to Benefit Immunotherapy Cancer Drugs
5
